surmount-1 tirzepatide trial obesity without diabetes after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide cuts diabetes risk by

The initial dose is not for full effect but for getting used to the medicine

Zepbound is an injectable medication that mimics two hormones, GLP-1 and GIP, to lower appetite and improve blood sugar control, while Contrave is a pill that combines two medications to curb cravings and emotional eating

If you stopped Ozempic for less than two weeks , you can typically restart at your previous maintenance dose once cleared by your medical team

Eur Thyroid J (2015) 4(2):938

Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss

See your healthcare provider regularly if you have prediabetes or are at increased risk for it